Delta CEO announces plan to share $1.4 billion in earnings with employees and hints at future of SkyMiles

Related Posts

Kaplan Fox & Kilsheimer LLP Investigates Potential Securities Law Violations Against TransMedics Group, Inc. (™DX) By Investing.com

NEW YORK – January 11, 2025 (NEWMEDIAWIRE) – Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against TransMedics Group (NASDAQ:), Inc. (TransMedics or the Company) (NASDAQ: ™DX). CLICK…

Investors are encouraged to contact Kaplan Fox before the lead plaintiff’s deadline of March 4, 2025 via Investing.com

NEW YORK – January 11, 2025 (NEWMEDIAWIRE) – Kaplan Fox & Kilsheimer LLP announced that a class action lawsuit has been filed against Revance Therapeutics (NASDAQ: ), Inc. (Revance or…

Leave a Reply

Your email address will not be published. Required fields are marked *